The Claim
In young male mice fed a high-fat diet, a 4-week treatment with an anti-myostatin antibody increased lean body mass by 7–9% and reduced adiposity by up to 35%, but did not improve insulin sensitivity, demonstrating that muscle hypertrophy induced by myostatin inhibition is insufficient to reverse diet-induced insulin resistance.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In young male mice on a high-fat diet, a 4-week anti-myostatin antibody treatment increased lean body mass by 7–9% and reduced fat mass by up to 35%, but did not improve insulin sensitivity.
See the scientific wording
In young male mice, a 4-week anti-myostatin antibody treatment increased lean body mass by 7–9% and reduced adiposity by up to 35% on a high-fat diet, but did not improve insulin sensitivity, indicating that muscle hypertrophy alone is insufficient to reverse diet-induced insulin resistance in young mammals.
Blocking myostatin makes muscles bigger, but in young mice eating a high-fat diet, fat tissue stays inflamed and resistant to insulin, so even with more muscle, the body cannot take up glucose properly.
What the research says
1 studyThe study found that blocking myostatin in older mice improved both muscle and how well their bodies used insulin — but the claim says this doesn’t work in young mice. Since the study shows insulin sensitivity CAN improve with this treatment, it contradicts the claim’s conclusion.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.